JP2006528213A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528213A5
JP2006528213A5 JP2006529739A JP2006529739A JP2006528213A5 JP 2006528213 A5 JP2006528213 A5 JP 2006528213A5 JP 2006529739 A JP2006529739 A JP 2006529739A JP 2006529739 A JP2006529739 A JP 2006529739A JP 2006528213 A5 JP2006528213 A5 JP 2006528213A5
Authority
JP
Japan
Prior art keywords
alkyl
unsubstituted
alkylene
mono
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006529739A
Other languages
English (en)
Japanese (ja)
Other versions
JP4658940B2 (ja
JP2006528213A (ja
Filing date
Publication date
Priority claimed from EP03011305A external-priority patent/EP1479676A1/en
Application filed filed Critical
Publication of JP2006528213A publication Critical patent/JP2006528213A/ja
Publication of JP2006528213A5 publication Critical patent/JP2006528213A5/ja
Application granted granted Critical
Publication of JP4658940B2 publication Critical patent/JP4658940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006529739A 2003-05-19 2004-05-05 第Xa因子阻害剤としてのベンゾイミダゾール誘導体 Expired - Fee Related JP4658940B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03011305A EP1479676A1 (en) 2003-05-19 2003-05-19 Benzimidazole-derivatives as factor xa inhibitors
PCT/EP2004/004750 WO2004101553A1 (en) 2003-05-19 2004-05-05 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS

Publications (3)

Publication Number Publication Date
JP2006528213A JP2006528213A (ja) 2006-12-14
JP2006528213A5 true JP2006528213A5 (enExample) 2007-05-24
JP4658940B2 JP4658940B2 (ja) 2011-03-23

Family

ID=33040952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529739A Expired - Fee Related JP4658940B2 (ja) 2003-05-19 2004-05-05 第Xa因子阻害剤としてのベンゾイミダゾール誘導体

Country Status (29)

Country Link
EP (2) EP1479676A1 (enExample)
JP (1) JP4658940B2 (enExample)
KR (1) KR20060014056A (enExample)
CN (2) CN101139346A (enExample)
AR (1) AR045683A1 (enExample)
AT (1) ATE474838T1 (enExample)
AU (1) AU2004238497B2 (enExample)
BR (1) BRPI0410446A (enExample)
CA (1) CA2526065A1 (enExample)
CL (1) CL2004001078A1 (enExample)
CR (1) CR8087A (enExample)
DE (1) DE602004028240D1 (enExample)
EC (1) ECSP056178A (enExample)
MA (1) MA27798A1 (enExample)
MX (1) MXPA05012231A (enExample)
NO (1) NO20055910L (enExample)
NZ (1) NZ543670A (enExample)
OA (1) OA13168A (enExample)
PA (1) PA8603501A1 (enExample)
PE (1) PE20050198A1 (enExample)
RS (1) RS20050856A (enExample)
RU (1) RU2346944C2 (enExample)
SA (1) SA04250196B1 (enExample)
TN (1) TNSN05297A1 (enExample)
TW (1) TW200503696A (enExample)
UA (1) UA82100C2 (enExample)
UY (1) UY28324A1 (enExample)
WO (1) WO2004101553A1 (enExample)
ZA (1) ZA200508151B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10342570A1 (de) * 2003-09-15 2005-04-14 Bayer Healthcare Ag Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon
US20060160799A1 (en) 2004-04-23 2006-07-20 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof
WO2008033739A2 (en) * 2006-09-12 2008-03-20 Neurogen Corporation Benzimidazole carboxamide derivatives
DE102010018299A1 (de) 2010-04-23 2011-10-27 Archimica Gmbh Verfahren zur Herstellung von 4-(4-Aminophenyl)-morpholin-3-on
CN105829293B (zh) * 2013-12-20 2018-11-09 中国人民解放军军事医学科学院毒物药物研究所 新型哌啶氨甲酰类化合物、制备方法及其用途
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
WO2019165374A1 (en) 2018-02-26 2019-08-29 Gilead Sciences, Inc. Substituted pyrrolizine compounds as hbv replication inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377642A (en) * 1971-01-14 1974-12-18 Koninklijke Gist Spiritus Penicillanic and cephalosporanic acid derivatives
US4269846A (en) * 1979-10-29 1981-05-26 Usv Pharmaceutical Corporation Heterocyclic compounds useful as anti-allergy agents
JPH0784462B2 (ja) * 1986-07-25 1995-09-13 日清製粉株式会社 ベンゾイミダゾ−ル誘導体
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
DE3828537A1 (de) * 1988-08-23 1990-03-01 Basf Ag Neue n-substituierte benzimidazol-2-carbonsaeureanilide, deren verwendung als lichtschutzmittel, insbesondere polymere und diese anilide enthaltendes organisches material
JPH0324609A (ja) * 1989-06-21 1991-02-01 Mitsuba Electric Mfg Co Ltd I/o用バッファic
JPH03184043A (ja) * 1989-12-14 1991-08-12 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
KR100190299B1 (ko) * 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
DE4304650A1 (de) * 1993-02-16 1994-08-18 Thomae Gmbh Dr K Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SI9520096A (sl) * 1994-09-30 1998-04-30 Pfizer Inc. Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina
JPH08208640A (ja) * 1995-02-06 1996-08-13 Nisshin Flour Milling Co Ltd ベンズイミダゾール誘導体およびそれを含有する心不全治療薬
JPH08295667A (ja) * 1995-04-27 1996-11-12 Takeda Chem Ind Ltd 複素環化合物、その製造法および剤
JPH09124609A (ja) * 1995-11-07 1997-05-13 Nissan Chem Ind Ltd ベンズイミダゾール誘導体
JPH10182459A (ja) * 1996-12-26 1998-07-07 Otsuka Pharmaceut Co Ltd cGMP分解酵素阻害剤
UA62972C2 (en) * 1997-07-03 2004-01-15 Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders
TR200002904T2 (tr) * 1998-04-10 2001-02-21 Japan Tobacco Inc. Amidin bileşikleri
RS20050201A (sr) * 2002-09-06 2007-06-04 Janssen Pharmaceutica N.V., Heterociklična jedinjenja

Similar Documents

Publication Publication Date Title
JP2006528942A5 (enExample)
JP2011507916A5 (enExample)
JP4585448B2 (ja) 第Xa因子阻害剤としてのピラゾール−誘導体
CA2777632C (en) Imidazole derivatives as casein kinase inhibitors
ES2291934T3 (es) Derivados de pirrol con actividad antibacteriana.
US8669266B2 (en) Quinoline-carboxamide derivatives as P2Y12 antagonists
ES2397401T3 (es) Derivados de aril-isoxazol-4-il-oxadiazol
AU2004238499A1 (en) Indazole-derivatives as factor Xa inhibitors
CA2709202A1 (en) Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
AU2009227013A1 (en) Novel heterocyclic compounds and uses therof
MX2013006467A (es) Compuestos biciclicos como inhibidores pim.
JP2006528213A5 (enExample)
AU2005301608A1 (en) Aryloxy-substituted benzimidazole derivatives
CA2526082A1 (en) Triazole-derivatives as factor xa inhibitors
PT2254881E (pt) Clorotiofeno-amidas como inibidores de factores de coagulação xa e da trombina
JP2006528214A5 (enExample)
WO2004101553B1 (en) BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
JP2011512367A5 (enExample)
MXPA05005498A (es) Derivados de imidazol como inhibidores del factor xa.
RU2005139557A (ru) Азаиндольные производные в качестве ингибиторов фактора ха
JP2008540589A5 (enExample)
RU2021100124A (ru) ПРОИЗВОДНЫЕ ТИОФЕНА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ, ВЫЗВАННЫХ IgE